Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...

BHV-1300 reduced total IgG by up to 84% in a four-week Phase 1 study. The treatment was well-tolerated, with no serious adverse events reported. Get access to the leaderboards pointing to tomorrow’s ...

WASHINGTON -- A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a researcher reported here. Patients receiving the infusion drug, ...

Please provide your email address to receive an email when new articles are posted on . Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing ...

People with muscle-specific kinase myasthenia gravis appear to have more active antibody responses in general, the study found. People with muscle-specific kinase (MuSK) myasthenia gravis (MG) have ...

Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobulin G (IgG) were less likely to experience severe infections compared with ...

IdeS IgG protease shows promise for Myasthenia Gravis, Immune Thrombocytopenia, and dozens of other IgG-driven autoimmune diseases. The wild type enzyme elicits potent anti-drug antibodies (ADA) that ...

Specific antibody deficiency (SAD) is an immune system disorder. It occurs when you have normal levels of antibodies but an insufficient immune response to certain types of bacteria. Antibodies, also ...